Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Prime Medicine is a leading biotechnology company focused on precise gene editing. Utilizing its innovative Prime Editing technology, it is developing transformative therapies to address a wide spectrum of genetic diseases. The company aims to fundamentally correct genomic defects, revolutionizing medicine.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Prime Medicine is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Prime Medicine last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.24 USD.
Across its last 3 earnings reports, Prime Medicine stock moved by ±10.5% on average the following day. The largest reaction was +13.6% on 10/31/2025; 1 of 3 reactions were positive.
Prime Medicine has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.